Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant COVID-19 Variant Vaccine (Sf9 Cell) booster

recombinant SARS-CoV-2 variant vaccine (Sf9 cell) booster · WestVac Biopharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant COVID-19 Variant Vaccine (Sf9 Cell) booster, covering 2025-03-28 to 2025-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster [Phase 2]

See pricing